Cargando…
Comparative methylome analysis identifies new tumour subtypes and biomarkers for transformation of nephrogenic rests into Wilms tumour
BACKGROUND: Wilms tumours (WTs) are characterised by several hallmarks that suggest epimutations such as aberrant DNA methylation are involved in tumour progression: loss of imprinting at 11p15, lack of recurrent mutations and formation of nephrogenic rests (NRs), which are lesions of retained undif...
Autores principales: | Charlton, Jocelyn, Williams, Richard D, Sebire, Neil J, Popov, Sergey, Vujanic, Gordan, Chagtai, Tasnim, Alcaide-German, Marisa, Morris, Tiffany, Butcher, Lee M, Guilhamon, Paul, Beck, Stephan, Pritchard-Jones, Kathy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354990/ https://www.ncbi.nlm.nih.gov/pubmed/25763109 http://dx.doi.org/10.1186/s13073-015-0136-4 |
Ejemplares similares
-
Methylome analysis identifies a Wilms tumor epigenetic biomarker detectable in blood
por: Charlton, Jocelyn, et al.
Publicado: (2014) -
Multiple mechanisms of MYCN dysregulation in Wilms tumour
por: Williams, Richard D., et al.
Publicado: (2015) -
TP53 Mutational Status Is a Potential Marker for Risk Stratification in Wilms Tumour with Diffuse Anaplasia
por: Maschietto, Mariana, et al.
Publicado: (2014) -
Bilateral Wilms tumour: a review of clinical and molecular features
por: Charlton, Jocelyn, et al.
Publicado: (2017) -
The treatment of Wilms' tumour: results of the United Kingdom Children's Cancer Study Group (UKCCSG) second Wilms' tumour study
por: Mitchell, C, et al.
Publicado: (2000)